Pediatric Endocrinology and Diabetes
The Division of Endocrinology and Diabetes at Children’s Mercy Kansas City is one of the largest and busiest in the country. With 25 pediatric endocrinologists and 4 nurse practitioners, it provides care to more than 12,000 patients in the region.
The division cares for children affected by general endocrine disorders and for those diagnosed with diabetes mellitus (type 1, type 2, and monogenic). The first pediatric program in the United States to be accredited by the American Diabetes Association, it cares for nearly 2,400 children diagnosed with type 1 and type 2 diabetes. In addition, our clinicians are also actively involved in treating rare conditions using a focused, multidisciplinary and comprehensive approach. A list of our “Focus” programs can be found in the Overview PDF.
Clinical research and quality improvement efforts aim to develop innovative concepts in technology, physiology, behavior, therapeutics, and patient health outcome improvements. These projects include initiatives such as nine NIH-funded studies, TrialNet, the T1D Exchange Quality Care Collaborative, and several clinical trials regarding new drugs for the treatment of type 1 and type 2 diabetes as well as growth disorders. In 2018, the division’s research funding was ~ 1.3 million dollars.
We are actively involved in basic/translational research with laboratory programs focused on bone growth and development and on novel modalities of insulin delivery.
In the academic year 2018-2019, the division’s research activities have led to the publication of 17 peer-reviewed manuscripts and 16 presentations at national and international meetings.
Through clinical and research efforts, the Division of Endocrinology and Diabetes at Children’s Mercy Kansas City was ranked by US News & World Report as one of the best Pediatric Endocrinology programs in the country.
To learn more about the Division of Endocrinology and Diabetes at Children’s Mercy Kansas City, click to download the PDF.